2009
DOI: 10.1016/j.mam.2009.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Anthrax toxins: A weapon to systematically dismantle the host immune defenses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
125
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 116 publications
(127 citation statements)
references
References 90 publications
2
125
0
Order By: Relevance
“…The most prominent effect of LT on macrophages is the induction of cell death (27,34,35). The LF present in LT cleaves and inactivates MAPKK1, MAPKK2, MAPKK3, MAPKK4, and MAPKK6, each of which plays an important role in MAPK-dependent immune activation, and the inactivation of the MAPKKs results in impaired host defenses (27,34,35).…”
Section: Resultsmentioning
confidence: 99%
“…The most prominent effect of LT on macrophages is the induction of cell death (27,34,35). The LF present in LT cleaves and inactivates MAPKK1, MAPKK2, MAPKK3, MAPKK4, and MAPKK6, each of which plays an important role in MAPK-dependent immune activation, and the inactivation of the MAPKKs results in impaired host defenses (27,34,35).…”
Section: Resultsmentioning
confidence: 99%
“…The most lethal form of the disease, inhalational anthrax, occurs when inhaled spores are phagocytosed by resident macrophages or dendritic cells and are carried to regional lymph nodes (1). En route, the bacteria germinate, escape the phagolysosome, and break out of the cell to replicate extracellularly, eventually leading to massive septicemia, shock, and death (2).…”
mentioning
confidence: 99%
“…3 The toxins modulate host immune responses leading to immune paralysis. 4,5 The mouse model has been, and still is, extensively used and has allowed significant advances in the understanding of key steps of anthrax. Using bioluminescent imaging, we recently followed in real time the kinetics and dissemination pattern of encapsulated nontoxinogenic or nonencapsulated toxinogenic B. anthracis during murine cutaneous, inhalational, and gastrointestinal infections.…”
mentioning
confidence: 99%